NewsRoom Articles - Page 1358 of 1436

TuesdayJan 31, 2017 12:00 pm

Excel Corp. (EXCC) Starts Presentation at NobleCon13

Excel Corporation (OTC: EXCC) provides integrated financial and transaction processing services to small and medium-sized businesses in the United States. The company provides an integrated suite of third-party merchant payment processing services and related proprietary software enabling products that deliver credit and debit card-based Internet payments processing solutions to small and mid-sized merchants operating in physical business environments, on the internet, and in retail settings requiring wired and wireless mobile payment solutions. For more information, visit the company’s website at www.excelcorpusa.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social…

TuesdayJan 31, 2017 12:00 pm

Bionik Laboratories Corp. (BNKL) Starts Presentation at NobleCon13

Bionik Laboratories (OTC: BNKL) is a medical device and robotics company focused on providing rehabilitation solutions and developing transformational technologies and solutions to individuals with neurological disorders. It specializes in designing, developing and commercializing physical rehabilitation technologies, prosthetics and assisted robotic products. The company offers InMotion Systems, which include the InMotion ARM that allows clinicians to deliver sensormotor therapy to the shoulder and elbow to develop new neural pathways; InMotion Hand, an add-on module to be used with the InMotion ARM; InMotion WRIST, which enables clinicians to deliver optimum intensive sensorimotor wrist and forearm therapy to patients with neurological conditions;…

TuesdayJan 31, 2017 11:30 am

OncoSec Medical, Inc. (NASDAQ: ONCS) Starts Presentation at NobleCon13

OncoSec Medical (NASDAQ: ONCS) designs, develops and commercializes gene therapies, therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer in the United States. Its lead product candidate is the ImmunoPulse IL-12, which is in phase II clinical trial for various indications, including metastatic melanoma and triple negative breast cancer. ImmunoPulse is an electroporation delivery device used in combination with the company’s therapeutic product candidates, including DNA plasmids that encode for immunologically active agents, and to deliver the therapeutic directly into the tumor. For more information, visit the company’s website at www.oncosec.com. About…

TuesdayJan 31, 2017 11:30 am

Synthesis Energy Systems, Inc. (NASDAQ: SYMX) Starts Presentation at NobleCon13

Synthesis Energy Systems (NASDAQ: SYMX) is an energy and gasification technology company that, together with its subsidiaries, provides proprietary gasification technology systems and solutions to the energy and chemical industries worldwide. The company offers U-GAS fluidized bed gasification technology that produces synthesis gas from various energy resources, including coal, biomass, municipal wastes, refuse derived fuels, and petroleum coke. Its synthesis gas can be converted into a range of energy and chemical products such as industrial fuel gas, substitute natural gas, electricity, hydrogen, ammonia and methanol. The company also has rights to sublicense U-GAS systems to third parties for coal, and…

TuesdayJan 31, 2017 11:00 am

Agile Therapeutics, Inc. (NASDAQ: AGRX) Starts Presentation at NobleCon13

Agile Therapeutics (NASDAQ: AGRX) is a specialty pharmaceutical company that focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate, Twirla, is a once-weekly contraceptive patch currently in phase III clinical development. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. For more information, visit…

TuesdayJan 31, 2017 11:00 am

Entravision Communications Corp. (NYSE: EVC) Starts Presentation at NobleCon13

Entravision Communications (NYSE: EVC) operates as a media company targeting and engaging Hispanics across media channels and advertising platforms in the United States and certain border markets of Mexico. The company operates through three segments: Television Broadcasting, Radio Broadcasting, and Digital Media. Entravision owns and operates television stations that broadcast drama shows, talk shows, novelas, entertainment magazines, news magazines, national news, specials, late news, children’s programs, sports, reality, comedy shows and movies; as well as owns and operates radio stations that broadcast advertising, news, traffic, weather, promotions and community events. In addition, it operates a proprietary technology and data platform…

TuesdayJan 31, 2017 11:00 am

Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) Starts Presentation at NobleCon13

Kratos Defense & Security Solutions (NASDAQ: KTOS) provides mission critical products, solutions and services primarily for the government and commercial customers. The company operates through three segments: Kratos Government Solutions, Unmanned Systems, and Public Safety & Security. The Kratos Government Solutions segment offers microwave electronic products; satellite communications; technical and training solutions; modular systems; and defense and rocket support services. The Unmanned Systems segment provides unmanned aerial, ground, seaborne and command, control and communications systems. For more information, visit the company’s website at www.kratosdefense.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full…

TuesdayJan 31, 2017 10:30 am

Delcath Systems, Inc. (NASDAQ: DCTH) Starts Presentation at NobleCon13

Delcath Systems (NASDAQ: DCTH) operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Delivery System; and markets melphalan hydrochloride as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan in Europe. Its primary focus is on the execution of its clinical development program in ocular melanoma liver metastases, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and certain other cancers that are metastatic to the liver. For more information, visit the company’s website at www.delcath.com. About NetworkNewsWire NetworkNewsWire…

TuesdayJan 31, 2017 10:30 am

KEYW Holding Corp. (NASDAQ: KEYW) Starts Presentation at NobleCon13

KEYW Holding (NASDAQ: KEYW) provides mission-critical cybersecurity, cyber superiority, and geospatial intelligence solutions in the United States. It operates in two segments, Government Solutions and Commercial Cyber Solutions. The company offers solutions, services and products to support the intelligence process, including the collection, processing, analysis and dissemination of intelligence information in the domains of cyberspace and geospace, as well as the protection of networks and related infrastructure. For more information, visit the company’s website at www.keywcorp.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted…

TuesdayJan 31, 2017 10:00 am

Heat Biologics, Inc. (NASDAQ: HTBX) Starts Presentation at NobleCon13

Heat Biologics (NASDAQ: HTBX) is a biopharmaceutical company focused on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against specific disease targets, such as cancer cells; and combination pan-antigen cytotoxic therapy. For more information, visit the company’s website at www.heatbio.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of…